IRIS
MASTROIANNI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.205
EU - Europa 154
AS - Asia 134
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.205
SG - Singapore 106
IT - Italia 49
IE - Irlanda 30
DE - Germania 21
CN - Cina 17
RU - Federazione Russa 11
GB - Regno Unito 10
CZ - Repubblica Ceca 8
FI - Finlandia 7
HK - Hong Kong 7
SE - Svezia 6
FR - Francia 5
UA - Ucraina 4
BE - Belgio 2
AU - Australia 1
BD - Bangladesh 1
EU - Europa 1
IN - India 1
KG - Kirghizistan 1
PL - Polonia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.496
Salva come PNG Salva come JPEG
Città #
Wilmington 440
Houston 277
Singapore 97
Woodbridge 81
Chandler 59
Fairfield 58
Rome 25
Santa Clara 25
New York 24
Ashburn 23
Cambridge 21
Seattle 20
Dublin 18
Ann Arbor 17
Dearborn 11
Medford 11
Beijing 6
Brno 6
Helsinki 6
Hong Kong 6
Lawrence 5
Munich 5
Engelhard 4
Moscow 4
Palo Alto 4
Colorado Springs 3
Jacksonville 3
Palermo 3
San Diego 3
Brussels 2
Council Bluffs 2
Guangzhou 2
Hounslow 2
Leeds 2
Los Angeles 2
Milan 2
Mt. Dora 2
Nanjing 2
North Hollywood 2
Nuremberg 2
Olomouc 2
Pisa 2
Pontedera 2
St. George 2
Wuxi 2
Xi'an 2
Atlanta 1
Bangalore 1
Canberra 1
Central 1
Clearwater 1
Genzano di Roma 1
Johannesburg 1
Kraków 1
Kunming 1
London 1
Nanchang 1
Phoenix 1
Redmond 1
Redwood City 1
San Francisco 1
Taipei 1
Xian 1
Totale 1.316
Salva come PNG Salva come JPEG
Nome #
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 295
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 286
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 249
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 235
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 173
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 39
Factors influencing place of death and disenrollment among patients receiving specialist palliative care 32
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 31
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 23
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 23
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 22
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 21
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 21
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 21
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 18
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 17
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 15
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 14
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 11
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 10
Totale 1.556
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020393 0 0 0 42 39 59 52 45 51 36 32 37
2020/2021263 27 32 27 37 28 31 27 32 7 7 4 4
2021/202269 1 5 3 3 7 3 7 4 12 5 5 14
2022/2023129 5 10 16 10 17 23 12 15 7 7 4 3
2023/2024145 16 5 3 1 9 19 0 4 6 59 1 22
2024/2025209 17 128 63 1 0 0 0 0 0 0 0 0
Totale 1.556